LONDON (UK) - Quanticate, a leading global data-focused clinical research organization (CRO), has launched a new Remote Source Data Verification (RSDV) Platform.
The 21 CFR part 11 compliant cloud-based application allows verification of multiple clinical research sites’ source data to be completed remotely by a specialist team at a centralized location.
We are excited to announce that we have again renewed our MSA with GlaxoSmithKline. Quanticate has been in partnership with GSK for several years and continues this key strategic partnership due to our outstanding quality and ability to deliver on time, every time. We will be supporting GSK on various phases and supplying highly skilled resources supporting various therapeutic areas – using a functional service provision and staff augmentation model. The renewal of this MSA demonstrates GSK’s trust in Quanticate as one of their preferred partners.
About Quanticate
Quanticate is exhibiting at this years PSI Online Conference, 21st - 23rd June 2021 and this years sponsor of the poster session.
Claude Price, Director of Clinical Data Management, will be speaking at the Outsourcing in Clinical Trials UK & Ireland 2021 Virtual Conference on 8th June at 1:50pm.
Deepu Joseph, VP of Clinical Data Management, will be hosting a roundtable discussion at the "Future Trials Roundtable Forum: Decentralized, Direct to Patient & Virtual Clinical Trials" on 13th May 2021 at 11:30 am & 12:30 pm EDT on “Virtual trials from a data perspective”
Deepu Joseph, VP of Clinical Data Management, will be speaking at the Outsourcing in Clinical Trials Europe 2021 - Virtual Conference on Day 2 (6th May) at 10:30am.
Quanticate, a leading global data-focused Clinical Research Organization (CRO), has announced a recruitment drive, with 60 roles in statistics and programming being hired over the next 6 months.
Quanticate is pleased to feature in the CPhI Monthly Podcast. Deepu Joseph and Fabian Du Fraise spoke with Gareth Carpenter about Decentralized Clinical Trials and the challenges that arise, the importance of clinical data and remote source data verification (RSDV).
LONDON (UK) - Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Lee Patterson as the company's Chief Operating Officer (COO).
Quanticate is pleased to partner with Antev Limited on a Phase II, Open-Label, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix Trifluoroacetate, a GnRH antagonist, in Participants with Advanced Prostate Cancer.
Prostate cancer is one of the most commonly diagnosed cancers and is a major cause of death in men worldwide. GnRH antagonists act by direct inhibition of GnRH receptors and therefore Luteinizing Hormone to reduce testosterone levels.
Quanticate is a Data Specialist CRO who has extensive experience supporting numerous oncology programs, including in prostate cancer. We are very much looking forward to supporting Antev on this important and crucial study by providing specialist statistics, programming, data management and medical writing solutions.
